2017
DOI: 10.1016/j.actbio.2017.10.009
|View full text |Cite
|
Sign up to set email alerts
|

Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles

Abstract: Gene transfer using lentiviral vectors has therapeutic applications spanning from monogenic and infectious diseases to cancer. Such gene therapy has to be improved by enhancing the levels of viral infection of target cells and/or reducing the amount of lentivirus for greater safety and reduced costs. Vectofusin-1, a recently developed cationic amphipathic peptide with a pronounced capacity to enhance such viral transduction, strongly promotes the entry of several retroviral pseudotypes into target cells when a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 32 publications
(30 citation statements)
references
References 64 publications
3
25
0
Order By: Relevance
“…[96][97][98][99][100] Higher pH, which is consistent with neutral histidines, was required for cell entry by the peptides. [101][102] Interestingly, the authors showed that these histidine-rich AMPs can be more disruptive when they adopt an in-plane rather than TM orientation. 12,103 An integrated model was proposed to explain how pH can affect the charges, structures, and topologies of the peptides.…”
Section: Discussionmentioning
confidence: 99%
“…[96][97][98][99][100] Higher pH, which is consistent with neutral histidines, was required for cell entry by the peptides. [101][102] Interestingly, the authors showed that these histidine-rich AMPs can be more disruptive when they adopt an in-plane rather than TM orientation. 12,103 An integrated model was proposed to explain how pH can affect the charges, structures, and topologies of the peptides.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, several studies about CAR T-cell manufacturing employed kits of the peptidic enhancers Vectofusin®-1 (Miltenyi Biotec) and Protransduzin™ (JPT Peptide Technologies). 353,354,528,529 However, popular materials in research cannot seamlessly be transferred to the clinical context. Low cell viability in high concentrations limits the application of Polybrene® (Abbott Laboratories Corp.) in drug formulations.…”
Section: Reviewmentioning
confidence: 99%
“…Whereas the interactions of antimicrobial peptides with lipids and other peptides within membranes have been the focus of prior biophysical investigations (Aisenbrey et al, 2019 ) much less is known about their interactions in solution. This is somewhat surprising because the potential of even very short polypeptides or extended amino acids to assemble into complex supramolecular assemblies has attracted increased attention in the context of biomaterials (Kumar et al, 2016 ; Chakraborty and Gazit, 2018 ; Beesley and Woolfson, 2019 ; Sun et al, 2019 ), biomedical applications (Fitzpatrick et al, 2013 ; Meier et al, 2014 ; Vermeer et al, 2017 ; Hainline et al, 2018 ) or amyloidogenic diseases (Fusco et al, 2016 ; Qiang et al, 2017 ; Ramamoorthy, 2018 ). Interestingly, the amyloid-beta peptide involved in Alzheimer disease has been found to not only assemble into fibrillar structures but to also exhibit antimicrobial activity (Soscia et al, 2010 ; Gosztyla et al, 2018 ).…”
Section: Introductionmentioning
confidence: 99%